The expression of β-amyloid peptides (Aβ),
a pathological
indicator of Alzheimer’s disease (AD), was reported to be inapparent
in the early stage of AD. While peroxynitrite (ONOO–) is produced excessively and emerges earlier than Aβ plaques
in the progression of AD, it is thus significant to sensitively detect
ONOO– for early diagnosis of AD and its pathological
research. Herein, we unveiled an integrated sensor for monitoring
ONOO–, which consisted of a commercially available
field-effect transistor (FET) and a high-performance multi-engineered
graphene extended-gate (EG) electrode. In the configuration of the
presented EG electrode, laser-induced graphene (LIG) intercalated
with MnO2 nanoparticles (MnO2/LIG) can improve
the electrical properties of LIG and the sensitivity of the sensor,
and graphene oxide (GO)-MnO2/Hemin nanozyme with ONOO– isomerase activity can selectively trigger the isomerization
of ONOO– to NO3
–. With
this synergistic effect, our EG-FET sensor can respond to the ONOO– with high sensitivity and selectivity. Moreover, taking
advantage of our EG-FET sensor, we modularly assembled a portable
sensing platform for wireless tracking ONOO– levels
in the brain tissue of AD transgenic mice at earlier stages before
massive Aβ plaques appeared, and we systematically explored
the complex role of ONOO– in the occurrence and
development of AD.